Komori
Shibuya (6340) · InitiativeFirst stated

Joint development of a real-time PCR testing device for simultaneous testing for COVID-19 and influenza

First written in FY2021. . Latest entry: FY2021.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
System Development for PCR and Single-Cell Analysis Instruments and Dedicated ReagentsA theme 4 companies write about · 0 as a headwind · 4 as a tailwind

0 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2021First statedAnnual report

    「The company jointly developed with スディックスバイオテック株式会社 of Kagoshima a real-time PCR testing device capable of simultaneously testing 3 viruses in a single specimen: COVID-19 and influenza A and B viruses.」

    The company states that it jointly developed a real-time PCR testing device capable of simultaneously testing 3 types of virus in a single specimen.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Shibuya's next results are scheduled for 2026-11-09. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.